Valuation: biote Corp.

Market Cap 73.71M 64.41M 59.44M 54.79M 103M 7.1B 106M 710M 279M 3.48B 277M 271M 11.97B P/E 2026 *
10.3x
P/E 2027 * 6.75x
Enterprise Value 160M 139M 129M 119M 224M 15.37B 229M 1.54B 605M 7.53B 599M 586M 25.91B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 0.71x
Free-Float
85.15%
Yield 2026 *
-
Yield 2027 * -
1 day+2.10%
1 week+4.29%
Current month+28.57%
1 month+7.05%
3 months+9.46%
6 months+4.74%
Current year-6.54%
1 week 2.1
Extreme 2.1002
2.53
1 month 1.63
Extreme 1.63
2.53
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
4.75
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-11
Chief Tech/Sci/R&D Officer 69 2024-02-29
Sales & Marketing - -
Director TitleAgeSince
Chairman 61 2022-04-30
Director/Board Member 51 2022-04-30
Director/Board Member 63 2022-04-30
Date Insider Type Main position Quantity % Market Cap.
6/12/26 Free

Chief Executive Officer

206,746 0.6816%
6/8/26 Free

Chairman

114,157 0.3764%
6/8/26 Free

Chief Executive Officer

130,000 0.4286%
Change 5-day change 1-year change 3-year change Capi.($)
+2.10%+4.29%-41.73%-67.64% 73.71M
-1.57%-3.47%-23.16%+20.56% 138M
+4.70%-4.38%-43.33%-91.05% 91.37M
0.00%0.00%+6.84%+8.70% 61.65M
+2.86%+0.52%-61.20%-61.28% 52.07M
Average +1.62%-0.61%-32.52%-38.14% 83.39M
Weighted average by Cap. +1.24%-1.29%-31.18%-31.47%

Financials

2026 *2027 *
Net sales 191M 167M 154M 142M 267M 18.36B 273M 1.84B 723M 8.99B 716M 700M 30.95B 205M 179M 165M 152M 287M 19.7B 293M 1.97B 776M 9.65B 768M 751M 33.22B
Net income 8.52M 7.45M 6.87M 6.33M 11.94M 820M 12.2M 82.12M 32.3M 402M 32M 31.29M 1.38B 12.82M 11.2M 10.33M 9.53M 17.95M 1.23B 18.35M 124M 48.58M 604M 48.13M 47.07M 2.08B
Net Debt 85.86M 75.03M 69.23M 63.82M 120M 8.27B 123M 828M 325M 4.05B 322M 315M 13.94B 71.8M 62.75M 57.9M 53.37M 101M 6.91B 103M 692M 272M 3.39B 270M 264M 11.66B
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
26-07-17 US$2.430 +2.10% 298,393
26-07-16 US$2.380 +9.68% 320,624
26-07-15 US$2.170 -0.91% 261,008
26-07-14 US$2.190 -5.60% 193,985
26-07-13 US$2.320 -0.43% 185,628
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.430USD
Average target price
2.732USD
Spread / Average Target
+12.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock